Globus Medical (GMED) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US3795772082

Globus Medical, Inc. is a renowned medical device company that focuses on developing and delivering healthcare solutions for individuals suffering from musculoskeletal disorders, both in the United States and across the globe.

The company specializes in a wide range of spine products, catering to various conditions such as degenerative issues, congenital disorders, deformities, tumors, and trauma injuries. These products include pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices.

Moreover, Globus Medical provides innovative treatment options for motion preservation technologies, interventional pain management solutions, as well as regenerative biologic products like allografts and synthetic alternatives.

Additionally, they offer orthopedic trauma products such as fracture plates, compression screws, intramedullary nails, and external fixation systems, along with hip and knee joint solutions including modular hip stems, acetabular cups, and knee arthroplasty implants.

Established in 2003, Globus Medical, Inc. is headquartered in Audubon, Pennsylvania, and continues to expand its product offerings to enhance the quality of life for patients worldwide. To learn more, visit their website at https://www.globusmedical.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Globus Medical (GMED) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Globus Medical (GMED) - Stock Price & Dividends

GMED Stock Overview

Market Cap in USD 7,371m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 2012-08-03

GMED Stock Ratings

Fundamental 2.62
Dividend -
Growth 5y 0.46
Rel. Performance vs Sector -1.74
Analysts 3.53/5
Fair Price Momentum 48.00 USD
Fair Price DCF 40.10 USD

GMED Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

GMED Growth Ratios

Growth 12m -0.77%
Growth Correlation 12m -36%
Growth Correlation 3m -13%
CAGR 5y 1.85%
Sharpe Ratio 12m -0.22
Alpha vs SP500 12m -29.93
Beta vs SP500 5y weekly 0.89
ValueRay RSI 48.47
Volatility GJR Garch 1y 36.38%
Price / SMA 50 -1.19%
Price / SMA 200 -0.19%
Current Volume 874.4k
Average Volume 20d 1075.5k

External Links for GMED Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of GMED stocks?
As of March 29, 2024, the stock is trading at USD 53.06 with a total of 874,390 shares traded.
Over the past week, the price has changed by +2.37%, over one month by -5.97%, over three months by -0.19% and over the past year by -0.58%.
What is the forecast for GMED stock price target?
According to ValueRays Forecast Model, GMED Globus Medical will be worth about 53.2 in March 2025. The stock is currently trading at 53.06. This means that the stock has a potential upside of +0.23%.
Issuer Forecast Upside
Wallstreet Target Price 61.6 16.1%
Analysts Target Price 67.3 26.7%
ValueRay Target Price 53.2 0.23%